Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program (ARRIVE 2)

This study has been completed.
Sponsor:
Information provided by:
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT00569751
First received: December 6, 2007
Last updated: September 25, 2008
Last verified: September 2008